Embleema, Inc. reported raising $3 Million in an initial SEC Form D filing, from an offering of $3.3 Million
Amount Raised
$3 Million
Round Type
Seed
Quick answer
Embleema raised $3 Million in a Seed round, dated January 9, 2019. Embleema is based in Boston, Massachusetts, United States.
- How much did Embleema raise?
- Embleema raised $3 Million in a Seed round on January 9, 2019.
- What does Embleema do?
- Embleema is a biotechnology company that focuses on innovative solutions for biosurveillance and biosecurity.
- Where is Embleema based and how big is it?
- Embleema is based in Boston, Massachusetts, United States. Fundz records about 32 employees.
Source: Fundz verified event record.
Who else raised in hospital & health care and Biotechnology around the same time
Companies in the same sectors as Embleema that raised within 45 days of this round, from Fundz verified event records.
- Climb Bio, Inc. raised $12M on February 19, 2019.
- SCWorx raised $25M on February 19, 2019.
- Castle Biosciences raised $8.7M on February 14, 2019.
- COMPLION INC. raised $6.8M on February 14, 2019.
- Viracta Therapeutics raised $5.7M on February 12, 2019.
- Myriad Genetics raised $249K (Pre-Seed) on February 12, 2019.
Who to call at Embleema, and when
A new round usually means Embleema is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Embleema raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Embleema, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Embleema. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Embleema raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Embleema raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.